The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease
Open accessAbstract
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common set of 7,893,274 variants across 13,708 cases and 95,282 controls. Twenty-six loci were identified as having genome-wide significant association; these and 6 additional previously reported loci were then tested in an independent set of 5,353 cases and 5,551 controls. Of the 32 tested SNPs, 24 replicated, including 6 newly identified loci. Conditional analyses within loci showed that four loci, including GBA, GAK-DGKQ, SNCA and the HLA region, contain a secondary independent risk variant. In total, we identified and replicated 28 independent risk variants for Parkinson's disease across 24 loci. Although the effect of each individual locus was small, risk profile analysis showed substantial cumulative risk in a comparison of the highest and lowest quintiles of genetic risk (odds ratio (OR) = 3.31, 95% confidence interval (CI) = 2.55-4.30; P = 2 × 10(-16)). We also show six risk loci associated with proximal gene expression or DNA methylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Subsequently, rare families with biallelic loss of function mutations in GRN were identified, and affected individuals were found to have a juvenile-onset neuronal ceroid lipofuscinosis (NCL).114–116”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [114]
Experimental — accuracy not yet measuredIn the citing paper
“While only <10% of the heritability of PD has been explained by current genetic findings (Darweesh et al., 2016; Nalls et al., 2014; Pihlstrom et al., 2016), and while the clinical utility of genetic testing for PD outside of early onset patient populations is limited (Klein & Westenberger, 2012), genetic risk models have been shown to predict PD status from healthy controls, or correlate with”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Nalls et al., 2014
In the citing paper
“First, a relatively small proportion (<10%) of the heritability of PD has been explained by current GWAS findings (Darweesh et al., 2016; Nalls et al., 2014; Pihlstrom et al., 2016)”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Nalls et al., 2014
In the citing paper
“A PD polygenic risk score was calculated using a weighted allele-counting approach (Dudbridge, 2013) based on known, common PD susceptibility loci, derived from the largest and most recent PD genome-wide association study (GWAS) meta-analysis (Nalls et al., 2014).”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Nalls et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. (2012) · Nature Genetics · doi:10.1038/ng.2354 · Cited by 1,737
The Rotterdam Study: objectives and design update
Albert Hofman, D., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A. P., Stricker, B. H. C., Tiemeier, H. W., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,408
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,338
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132
Nalls, M. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 922
Self-citationHamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 808
Self-citationAbundant quantitative trait loci exist for DNA methylation and gene expression in human brain
Gibbs, J. R., van der Brug, M. P., Hernandez, D. G., Traynor, B. J., Nalls, M. A., Lai, S.-L., Arepalli, S., Dillman, A., Rafferty, I. P., Troncoso, J., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000952 · Cited by 769
Self-citationHan, B., & Eskin, E. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.014 · Cited by 680
Flagged first, then by citations
2 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,004
Head injury, potential interaction with genes, and risk for Parkinson's disease
Gao, J., Liu, R., Zhao, E. J., Huang, X., Nalls, M. A., Singleton, A., & Chen, H. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.12.033 · Cited by 30
Self-citationEssential role of Ufm1 conjugation in the hematopoietic system
Cai, Y., Singh, N., & Li, H. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.03.007 · Cited by 30
van Bree, E. J., Guimarães, R. L. F. P., Lundberg, M., Blujdea, E. R., Rosenkrantz, J. L., White, F. T. G., Poppinga, J., Ferrer‐Raventós, P., Schneider, A.-F. E., Clayton, I., et al. (2022) · Genome Research · doi:10.1101/gr.275515.121 · Cited by 30
Yang, C., Farias, F. G., Ibáñez, L., Sadler, B. E., Fernández, M. V., Wang, F., Bradley, J. L., Eiffert, B., Bahena, J. A., Budde, J., et al. (2020) · medRxiv · doi:10.1101/2020.06.25.20140277 · Cited by 29
Dysfunction of synaptic endocytic trafficking in Parkinson’s disease
Ng, X. Y., & Cao, M. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01624 · Cited by 31
Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders
Scholz, S. W., & Brás, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024629 · Cited by 30
Trans -pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci
Chan, G., White, C. C., Winn, P. A., Cimpean, M., Replogle, J. M., Glick, L. R., Cuerdon, N., Ryan, K. J., Johnson, K. A., Schneider, J. A., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000090 · Cited by 28
Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy
Kara, E., Marks, J. D., & Aguzzi, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.004 · Cited by 30
Self-citationLi, J., Jew, B., Zhan, L., Hwang, S., Coppola, G., Freimer, N. B., & Sul, J. H. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007556 · Cited by 29
Cell and Tissue Instructive Materials for Central Nervous System Repair
Rocha, L. A., Silva, D., Barata‐Antunes, S., Cavaleiro, H., Gomes, E. D., Silva, N. A., & Salgado, A. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909083 · Cited by 31
Endosomal sorting pathways in the pathogenesis of Parkinson's disease
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2020.02.001 · Cited by 25
Targeted RNA sequencing enhances gene expression profiling of ultra-low input samples
Curion, F., Handel, A. E., Attar, M., Gallone, G., Bowden, R. J., Cader, M. Z., & Clark, M. B. (2020) · RNA Biology · doi:10.1080/15476286.2020.1777768 · Cited by 29
Post-GWAS knowledge gap: the how, where, and when
Pierce, S. E., Booms, A., Prahl, J. D., der Schans, E. J. C. V., Tyson, T., & Coetzee, G. A. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-00125-y · Cited by 31
Accelerating diagnosis of Parkinson’s disease through risk prediction
Yuan, W., Beaulieu‐Jones, B. K., Krolewski, R. C., Palmer, N., Veyrat‐Follet, C., Frau, F., Cohen, C., Bozzi, S., Cogswell, M., Kumar, D., et al. (2021) · BMC Neurology · doi:10.1186/s12883-021-02226-4 · Cited by 32
Albanese, F., Mercatelli, D., Finetti, L., Lamonaca, G., Pizzi, S., Shimshek, D. R., Bernacchia, G., & Morari, M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105487 · Cited by 29
Luo, X., Kang, X., & Schönhuth, A. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-022-00604-2 · Cited by 29
Transmembrane Protein 175, a Lysosomal Ion Channel Related to Parkinson’s Disease
Tang, T., Jian, B., & Liu, Z. (2023) · Biomolecules · doi:10.3390/biom13050802 · Cited by 31
Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps
The International Parkinson Disease Genomics Consortium (IPDGC) (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191854 · Cited by 29
Ng, X. Y., Wu, Y., Lin, Y., Yaqoob, S. M., Greene, L. E., Camilli, P. V. D., & Cao, M. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00465-5 · Cited by 28
Association Study between the CD157/BST1 Gene and Autism Spectrum Disorders in a Japanese Population
Yokoyama, S., Mahmuda, N. A., Munesue, T., Hayashi, K., Yagi, K., Yamagishi, M., & Higashida, H. (2015) · Brain Sciences · doi:10.3390/brainsci5020188 · Cited by 29
HaghNejad, L., Emamalizadeh, B., Jamshidi, J., Bidoki, A. Z., Ghaedi, H., Ahmadi, E., Abdollahi, S., Shahmohammadibeni, N., Taghavi, S., Fazeli, A., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.020 · Cited by 28
Gene regulatory effects of disease-associated variation in the NRF2 network
Lacher, S. E., & Slattery, M. G. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.001 · Cited by 27
Convergent pathways in Parkinson’s disease
Cherubini, M., & Wade‐Martins, R. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2700-2 · Cited by 28
Hall, A., Bandrés‐Ciga, S., Díez-Fairén, M., Quinn, J. P., & Billingsley, K. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197332 · Cited by 27
MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062953 · Cited by 28
Østvold, A. C., Grundt, K., & Wiese, C. (2022) · Biochemical Journal · doi:10.1042/bcj20220075 · Cited by 28
Zhang, L., Liu, Y., Lu, Y., & Wang, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115295 · Cited by 29
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
Tunold, J., Tan, M. M. X., Koga, S., Geut, H., Rozemüller, A. J. M., Valentino, R. R., Sekiya, H., Martin, N. B., Heckman, M. G., Brás, J., et al. (2023) · Brain · doi:10.1093/brain/awad183 · Cited by 29
Genetic markers of Restless Legs Syndrome in Parkinson disease
Gan‐Or, Z., Alcalay, R. N., Bar‐Shira, A., Leblond, C. S., Postuma, R. B., Ben‐Shachar, S., Waters, C., Johnson, A., Levy, O., Mirelman, A., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.03.010 · Cited by 28
Zhang, M., Mu, H., Shang, Z., Kang, K., Lv, H., Duan, L., Li, J., Chen, X., Teng, Y., Jiang, Y., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.004 · Cited by 28
Roles of NUCKS1 in Diseases: Susceptibility, Potential Biomarker, and Regulatory Mechanisms
Huang, P., Cai, Y., Zhao, B., & Cui, L. (2018) · BioMed Research International · doi:10.1155/2018/7969068 · Cited by 27
Sun, L. V., Zhang, J., Chen, W., Chen, Y., Zhang, X., Yang, M., Xiao, M., Ma, F., Yao, Y., Ye, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13210 · Cited by 23
Progress toward an integrated understanding of Parkinson’s disease
Rousseaux, M. W. C., Shulman, J. M., & Jankovic, J. J. (2017) · F1000Research · doi:10.12688/f1000research.11820.1 · Cited by 27
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
Lim, S., Kim, H., Kim, D., & Lee, S. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.010 · Cited by 28
Ramezani, M., Wilkes, M. M., Das, T., Holowka, D., Eliezer, D., & Baird, B. A. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0084-6 · Cited by 27
Sharma, A., Osato, N., Liu, H., Asthana, S., Dakal, T. C., Ambrosini, G., Bücher, P., Schmitt, I., & Wüllner, U. (2019) · Scientific Reports · doi:10.1038/s41598-019-54865-w · Cited by 27
Mutation analysis of TMEM family members for early-onset Parkinson’s disease in Chinese population
Li, C., Ou, R., Chen, Y., Gu, X., Wei, Q., Cao, B., Zhang, L., Hou, Y., Liu, K., Chen, X., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.11.005 · Cited by 27
Ichise, E., Chiyonobu, T., Ishikawa, M., Tanaka, Y., Shibata, M., Tozawa, T., Taura, Y., Yamashita, S., Yoshida, M., Morimoto, M., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab113 · Cited by 27
Tripathi, A., Alnakhala, H., Terry-Kantor, E., Newman, A., Liu, L., Imberdis, T., Fanning, S., Nuber, S., Ramalingam, N., Selkoe, D., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1881-21.2022 · Cited by 27
Biomarker characterization of clinical subtypes of Parkinson Disease
Deng, X., Saffari, S. E., Liu, N., Xiao, B., Allen, J. C., Ng, S. Y., Chia, N. S. Y., Tan, Y. J., Choi, X., Heng, D. L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00375-y · Cited by 27
The Endo-lysosomal System in Parkinson’s Disease: Expanding the Horizon
Muraleedharan, A., & Vanderperre, B. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168140 · Cited by 27
Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico
Sesar, Á., Cacheiro, P., López, M., Camiña-Tato, M., Quintáns, B., Monroy‐Jaramillo, N., Alonso-Vilatela, M. E., Cebrián, E., Yescas, P., Ares, B., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.014 · Cited by 27
Genetic variation associated with the occurrence and progression of neurological disorders
Little, J., Barakat, C., Martino, R., Pringsheim, T. M., Tremlett, H. L., McKay, K. A., Lieshout, P. H. H. M. V., Walsh, S. J., Gomes, J., & Krewski, D. R. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.09.018 · Cited by 28
Association between DNA methyltransferase gene polymorphism and Parkinson’s disease
Pezzi, J. C., Ens, C. M. B., da Rocha, T. J., Schuh, A. F. S., Chaves, M. L. F., Rieder, C. R. D. M., Hutz, M. H., Fiegenbaum, M., & Camozzato, A. L. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.058 · Cited by 27
Zhou, W., Fritsche, L. G., Das, S., Zhang, H., Nielsen, J. B., Holmen, O. L., Chen, J., Lin, M., Elvestad, M. B., Hveem, K., et al. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22067 · Cited by 27
Kinases in synaptic development and neurological diseases
Baltussen, L. L., Roşianu, F., & Ultanir, S. K. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.006 · Cited by 31
Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid
Kalia, L. V. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.11.016 · Cited by 27
Fernández‐Santiago, R., Martín‐Flores, N., Antonelli, F., Cerquera‐Cleves, C., Moreno, V., Bandrés‐Ciga, S., Manduchi, E., Tolosa, E. S., Singleton, A., Moore, J. H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27770 · Cited by 27
Self-citationCoding variation in GBA explains the majority of the SYT11‐GBA Parkinson's disease GWAS locus
Blauwendraat, C., Brás, J., Nalls, M. A., Lewis, P. A., Hernandez, D. G., & Singleton, A. (2018) · Movement Disorders · doi:10.1002/mds.103 · Cited by 25
Self-citationYang, N., Zhao, Y., Liu, Z., Zhang, R., He, Y., Zhou, Y., Xu, Q., Sun, Q., Yan, X., Guo, J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.012 · Cited by 26
Analysis of common and rare VPS13C variants in late-onset Parkinson disease
Rudakou, U., Ruskey, J. A., Krohn, L., Laurent, S. B., Spiegelman, D., Greenbaum, L., Yahalom, G., Désautels, A., Montplaisir, J. Y., Fahn, S., et al. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000385 · Cited by 26
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 27
Allele-specific expression of Parkinson’s disease susceptibility genes in human brain
Langmyhr, M., Henriksen, S. P., Cappelletti, C., van de Berg, W. D. J., Pihlstrøm, L., & Toft, M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79990-9 · Cited by 28
Zimmermann, M., Köhler, L., Kovářová, M., Lerche, S., Schulte, C., Wurster, I., Machetanz, G., Deuschle, C., Hauser, A., Gasser, T., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14733 · Cited by 26
Self-citationLiao, H., Winkler, J., Wißfeld, J., Shahraz, A., Klaus, C., & Neumann, H. (2021) · Glia · doi:10.1002/glia.24073 · Cited by 29
Zhao, Y., Pan, H.-X., Liu, Z., Wang, Y., Zeng, Q., Fang, Z., Luo, T., Xu, K., Wang, Z., Zhou, X. C., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749109 · Cited by 27
GCH1 deficiency activates brain innate immune response and impairs tyrosine hydroxylase homeostasis
Larbalestier, H., Keatinge, M., Watson, L., White, E., Gowda, S., Wei, W., Koler, K., Semenova, S., Elkin, A., Rimmer, N., et al. (2022) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 26
What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Fernández‐Santiago, R., & Sharma, M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101648 · Cited by 26
Self-citationBahrami, S., Nordengen, K., Shadrin, A. A., Frei, O., van der Meer, D., Dale, A. M., Westlye, L. T., Andreassen, O. A., & Kaufmann, T. (2022) · Nature Communications · doi:10.1038/s41467-022-31086-w · Cited by 26
Akwa, Y., Malta, C. D., Zallo, F., Gondard, E., Lunati, A., Diaz-de-Grenu, L. Z., Zampelli, A., Boiret, A., Santamaria, S., Martinez-Preciado, M., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2095791 · Cited by 27
Dang, X., Zhang, Z., & Luo, X. (2022) · Movement Disorders · doi:10.1002/mds.29239 · Cited by 25
Palomba, N. P., Fortunato, G., Pepe, G., Modugno, N., Pietracupa, S., Damiano, I., Mascio, G., Carrillo, F., Giovannantonio, L. G. D., Ianiro, L., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03203-9 · Cited by 27
EIF4G1 mutations do not cause Parkinson's disease
Nichols, N., Brás, J., Hernandez, D. G., Jansen, I. E., Lesage, S., Lubbe, S. J., & Singleton, A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.017 · Cited by 26
Self-citationWhat lysosomes actually tell us about Parkinson’s disease?
Bourdenx, M., & Dehay, B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.02.008 · Cited by 26
Schlossmacher, M. G., Tomlinson, J. J., dos Santos, G. M., Shutinoski, B., Brown, E. G., Manuel, D. G., & Mestre, T. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13476 · Cited by 31
Parkinson's Disease: Patients’ Knowledge, Attitudes, and Interest in Genetic Counseling
Maloney, K. A., Alaeddin, D. S., von Coelln, R., Dixon, S., Shulman, L. M., Schrader, K., & Guan, Y. (2018) · Journal of Genetic Counseling · doi:10.1007/s10897-018-0239-3 · Cited by 25
Carrillo-Jiménez, A., Puigdellívol, M., Vilalta, A., Venero, J. L., Brown, G. C., George‐Hyslop, P. S., & Burguillos, M. Á. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00313 · Cited by 26
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
Chittoor-Vinod, V. G., Nichols, R. J., & Schüle, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031045 · Cited by 26
The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease
Gan‐Or, Z., Amshalom, I., Bar‐Shira, A., Gana‐Weisz, M., Mirelman, A., Marder, K. S., Bressman, S., Giladi, N., & Orr‐Urtreger, A. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7868-3 · Cited by 24
Self-citationMariani, E., Lombardini, L., Facchin, F., Pizzetti, F., Frabetti, F., Tarozzi, A., & Casadei, R. (2018) · Genes · doi:10.3390/genes9060275 · Cited by 25
Genetic risk variants for brain disorders are enriched in cortical H3K27ac domains
Hannon, E. J., Marzi, S. J., Schalkwyk, L. C., & Mill, J. S. (2019) · Molecular Brain · doi:10.1186/s13041-019-0429-4 · Cited by 25
Epigenetics in Multiple Sclerosis
Chan, V. S. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3449-2_12 · Cited by 27
Kao, C., Xu, M., Wang, L., Lin, S., Lee, H.-J., Duraine, L., Bellen, H. J., Goldstein, D. S., Tsai, S. Y., & Tsai, M. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008868 · Cited by 25
VPS13C-associated Parkinson's disease: Two novel cases and review of the literature
Monfrini, E., Spagnolo, F., Canesi, M., Seresini, A., Rini, A., Passarella, B., Percetti, M., Seia, M., Goldwurm, S., Cereda, V., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.11.031 · Cited by 25
Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study
Grover, S., & Sharma, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.765321 · Cited by 26
Self-citationSaleem, U., Hussain, L., shahid, F., Anwar, F., Chauhdary, Z., & Zafar, A. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3697522 · Cited by 25
Pini, L., Salvalaggio, A., Wennberg, A. M. V., Dimakou, A., Matteoli, M., & Corbetta, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101867 · Cited by 26
Naaldijk, Y., Fernández, B., Fasiczka, R., Fdez, E., Leghay, C., Croitoru, I. M., Kwok, J. B., Boulesnane, Y., Vizeneux, A., Mutez, E., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00624-8 · Cited by 26
Basavarajappa, B. S., & Subbanna, S. (2024) · Epigenomics · doi:10.2217/epi-2023-0428 · Cited by 24
Puschmann, A., Brighina, L., Markopoulou, K., Aasly, J. O., Chung, S. J., Frigerio, R., Hadjigeorgiou, G. M., Kõks, S., Krüger, R., Siuda, J. S., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.029 · Cited by 25
Self-citationPolimanti, R. A., Chen, C., Ursano, R. J., Heeringa, S. G., Jain, S., Kessler, R. C., Nock, M. K., Smoller, J. W., Sun, X., Gelernter, J. E., et al. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4550 · Cited by 25
MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics
Ramaswamy, P., Christopher, R., Pal, P. K., & Yadav, R. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.032 · Cited by 25
LRRK2 and membrane trafficking: nexus of Parkinson's disease
Hur, E., Jang, E., Jeong, G. R., & Lee, B. D. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.9.186 · Cited by 27
The contribution of C. elegans neurogenetics to understanding neurodegenerative diseases
Liang, J., McKinnon, I. A., & Rankin, C. H. (2020) · Journal of Neurogenetics · doi:10.1080/01677063.2020.1803302 · Cited by 28
Parkinsonism in GTP cyclohydrolase 1 mutation carriers
Guella, I., Sherman, H. E., Appel‐Cresswell, S., Rajput, A. H., Rajput, A. H., & Farrer, M. J. (2014) · Brain · doi:10.1093/brain/awu341 · Cited by 25
Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
Xicoy, H., Klemann, C. J. H. M., Witte, W. D., Martens, M. B., Martens, G. J. M., & Poelmans, G. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00168-9 · Cited by 24
Identify Complex Imaging Genetic Patterns via Fusion Self-Expressive Network Analysis
Wang, M., Shao, W., Hao, X., & Zhang, D. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2021.3063785 · Cited by 24
Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
Figura, M., Sitkiewicz, E., Świderska, B., Milanowski, Ł., Szlufik, S., Koziorowski, D., & Friedman, A. (2021) · Brain Sciences · doi:10.3390/brainsci11050661 · Cited by 24
Abe, T., & Kuwahara, T. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.681369 · Cited by 24
Contribution of rare variant associations to neurodegenerative disease presentation
Dilliott, A. A., Abdelhady, A., Sunderland, K. M., Farhan, S. M. K., Abrahão, A., Binns, M. A., Black, S. E., BORRIE, M. J., Casaubon, L. K., Dowlatshahi, D. D., et al. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00243-3 · Cited by 24
Lerche, S., Zimmermann, M., Röeben, B., Wurster, I., Fries, F. L., Deuschle, C., Waniek, K., Lachmann, I., Jakobi, M., Joos, T. O., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00476-2 · Cited by 29
Obergasteiger, J., Castonguay, A.-M., Pizzi, S., Magnabosco, S., Frapporti, G., Lobbestael, E., Baekelandt, V., Hicks, A. A., Pramstaller, P. P., Gravel, C., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00484-2 · Cited by 24
Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
Piper, D., Sastre, D., & Schüle, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00199 · Cited by 23
S100B polymorphisms are associated with age of onset of Parkinson’s disease
Fardell, C., Zettergren, A., Ran, C., Belin, A. C., Ekman, A., Sydow, O., Bäckman, L., Holmberg, B., Dizdar, N., Söderkvist, P., et al. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0547-3 · Cited by 24
Parkinson's disease across ethnicities: A nationwide study in New Zealand
Pitcher, T. L., Myall, D. J., Pearson, J. F., Lacey, C. J., Dalrymple‐Alford, J. C., Anderson, T., & MacAskill, M. R. (2018) · Movement Disorders · doi:10.1002/mds.27389 · Cited by 24
Cresto, N., Gaillard, M., Gardier, C., Gubinelli, F., Diguet, E., Bellet, D., Legroux, L., Mitja, J., Aurégan, G., Guillermier, M., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104614 · Cited by 24
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease
Tan, Y., Sgobio, C., Arzberger, T., Machleid, F., Tang, Q., Findeis, E., Tost, J., Chakroun, T., Gao, P., Höllerhage, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02099-5 · Cited by 24
Ye, G., Li, Y., Zhou, L., Zhang, Y., Zhu, L., Zhao, A., Kang, W., & Liu, J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202243 · Cited by 24
Ullah, E., Mall, R., Abbas, M. M., Kunji, K. B., Nato, A. Q., Bensmail, H., Wijsman, E. M., & Saad, M. (2018) · Genome Research · doi:10.1101/gr.236315.118 · Cited by 25
Self-citationPike, S. C., Havrda, M. C., Gilli, F., Zhang, Z., & Salas, L. A. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00626-6 · Cited by 26
Metadata
- Authors
- International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson's Disease Consortium, Alzheimer Genetic Analysis Group, Pankratz, N., Lill, C. M., Do, C. B., Hernandez, D. G., Saad, M., DeStefano, A. L., Kara, E., Bras, J., Sharma, M., Schulte, C., Keller, M. F., Arepalli, S., Letson, C., Edsall, C., Stefansson, H., Liu, X., Pliner, H., Lee, J. H., Cheng, R., Ikram, M. A., Ioannidis, J. P. A., Hadjigeorgiou, G. M., Bis, J. C., Martinez, M., Perlmutter, J. S., Goate, A., Marder, K., Fiske, B., Sutherland, M., Xiromerisiou, G., Myers, R. H., Clark, L. N., Stefansson, K., Hardy, J. A., Heutink, P., Chen, H., Wood, N. W., Houlden, H., Payami, H., Brice, A., Scott, W. K., Gasser, T., Bertram, L., Eriksson, N., Foroud, T., & Singleton, A. B.
- Affiliations
- National Institutes of Health (US)
- University of Minnesota (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- 23andMe (United States) (US)
- National Hospital for Neurology and Neurosurgery (GB)
- Boston University (US)
- National Institute on Aging (US)
- Université Toulouse III - Paul Sabatier (FR)
- Columbia University Irving Medical Center (US)
- University of Thessaly (GR)
- University of Washington (US)
- Washington University in St. Louis (US)
- deCODE Genetics (Iceland) (IS)
- New York State Department of Health (US)
- University of Miami (US)
- Hertie Institute for Clinical Brain Research (DE)
- Centre National de la Recherche Scientifique (FR)
- Max Planck Institute for Molecular Genetics (DE)
- Indiana University Indianapolis (US)
- Corresponding author
- Singleton, Andrew B
- ORCID
- Nalls, Mike A
- Pankratz, Nathan
- Lill, Christina M
- Hernandez, Dena G
- Saad, Mohamad
- DeStefano, Anita L
- Kara, Eleanna
- Sharma, Manu
- Schulte, Claudia
- Keller, Margaux F
- Letson, Christopher
- Edsall, Connor
- Liu, Xinmin
- Pliner, Hannah
- Lee, Joseph H
- Cheng, Rong
- Ikram, M Arfan
- Ioannidis, John P A
- Bis, Joshua C
- Martinez, Maria
- Perlmutter, Joel S
- Goate, Alison
- Marder, Karen
- Fiske, Brian
- Sutherland, Margaret
- Xiromerisiou, Georgia
- Myers, Richard H
- Clark, Lorraine N
- Hardy, John A
- Heutink, Peter
- Chen, Honglei
- Wood, Nicholas W
- Houlden, Henry
- Payami, Haydeh
- Brice, Alexis
- Scott, William K
- Gasser, Thomas
- Bertram, Lars
- Foroud, Tatiana
- Singleton, Andrew B
- Venue
- Nature Genetics
- Published
- 2014-09
- Volume
- 46
- Issue
- 9
- Pages
- 989-993
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4146673
- OpenAlex
- W2141459724
- Cited by
- 1,895
- References
- 40
- Citations by year
- 2026: 67 · 2025: 86 · 2024: 103 · 2023: 142 · 2022: 182 · 2021: 194 · 2020: 187 · 2019: 176 · 2018: 212 · 2017: 194 · 2016: 185 · 2015: 140 · 2014: 25
- FWCI
- 24.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- DZNE Pub (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- Wellcome Trust (085475, 083948/Z/07/Z, 090355, 089698, 076113, WT089698/Z/09/Z)
- National Institute for Health and Care Research (ACF-2012-17-017)
- Parkinson's UK (F-1202, G-0907, G0909, J‐0804)
- National Institutes of Health (1r01hl120393-01a1, UL1TR001108, UL1TR000124, 5r44hg006981-03, Z01-AG000949)
- Medical Research Council (MC_G1000735, MR/J004758/1, MC_PC_09003, MR/L501554/1, MR/L010305/1, MR/L016400/1, MC_G0901330)
- National Institute on Aging (Z01AG000932, AG-16495, R01AG031287, AG031287, P30AG024826, AG08122, AG033193, AG025259, AG023629, R01AG041797, R01AG016495, P30AG013846, R01AG025259, R01AG033193, R01AG008122, U24AG056270, U24AG021886)
- National Heart, Lung, and Blood Institute (R01-HL120393)
- National Human Genome Research Institute (R44-HG006981)
- National Cancer Institute (R01CA141668)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, P30DK063491)
- National Institute of Neurological Disorders and Stroke (R01NS037167, R21NS050487, NS036630, R01NS036960, NS050487, K23NS070867, R01 NS 36960, NS17950, U01NS082151, R01NS088538, P50NS038377, R01NS076843, R01NS075321, R01NS060113, P50NS071674, K02NS073836, R01NS017950, NS060113)
- National Center for Research Resources (UL1RR024156, KL2RR024154)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, genetic susceptibility loci, genome-wide association study, risk alleles, glucocerebrosidase, SNCA, HLA region, conditional analysis, cumulative genetic risk, gene expression, DNA methylation, replication
- MeSH terms
- Genotype, Humans, Parkinson Disease, Risk Factors, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
